𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Conserved fate and function of ferumoxides-labeled neural precursor cells in vitro and in vivo

✍ Scribed by Mikhal E. Cohen; Naser Muja; Nina Fainstein; Jeff W.M. Bulte; Tamir Ben-Hur


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
561 KB
Volume
88
Category
Article
ISSN
0360-4012

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Recent progress in cell therapy research for brain diseases has raised the need for non‐invasive monitoring of transplanted cells. For therapeutic application in multiple sclerosis, transplanted cells need to be tracked both spatially and temporally, in order to assess their migration and survival in the host tissue. Magnetic resonance imaging (MRI) of superparamagnetic iron oxide‐(SPIO)‐labeled cells has been widely used for high resolution monitoring of the biodistribution of cells after transplantation into the central nervous system (CNS). Here we labeled mouse glial‐committed neural precursor cells (NPCs) with the clinically approved SPIO contrast agent ferumoxides and examined their survival and differentiation in vitro, as well as their functional response to environmental signals present within the inflamed brain of experimental autoimmune encephalomyelitis (EAE) mice in vivo. We show that ferumoxides labeling does not affect NPC survival and pluripotency in vitro. Following intracerebroventricular (ICV) transplantation in EAE mice, ferumoxides‐labeled NPCs responded to inflammatory cues in a similar fashion as unlabeled cells. Ferumoxides‐labeled NPCs migrated over comparable distances in white matter tracts and differentiated equally into the glial lineages. Furthermore, ferumoxides‐labeled NPCs inhibited lymph node cell proliferation in vitro, similarly to non‐labeled cells, suggesting a preserved immunomodulatory function. These results demonstrate that ferumoxides‐based MRI cell tracking is well suited for non‐invasive monitoring of NPC transplantation. © 2009 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Contrasting in vivo and in vitro fates o
✍ Ajay Pandita; Kenneth D. Aldape; Gelareh Zadeh; Abhijit Guha; C. David James 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB

Despite the high incidence of EGFR amplification in patient glioblastoma multiforme (GBM) tissues, only a single GBM cell line, of the many described in the literature, is known to contain and maintain amplified EGFR. Because EGFR mutations in GBM manifest primarily, if not exclusively, in amplified

In vivo versus in vitro assays for asses
✍ Martin F. Bachmann; Thomas M. Kündig 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 885 KB

As mice deficient in a particular gene provide an increasing number of novel in vivo models, in vivo assays that examine immune function are becoming a central issue. We found that the sensitivities of in vivo and in vitro assays are strikingly different. These differences have important implication

Serial in vivo loss and in vitro gain of
✍ Soroosh Radfar; Christian Davrinche; Etienne Hollande 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 512 KB

## Abstract Recent studies have shown the involvement of the Fas system (Fas receptor and its ligand FasL) in cancerous processes. The absence or downregulation of Fas, reported in the majority of human tumors, conflicts with its presence in cancerous cells from the same tumors but maintained __in

Retroviral labeling of Schwann cells: In
✍ Afshin Mosahebi; Barbara Woodward; Mikael Wiberg; Robin Martin; Giorgio Terenghi 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

## Abstract Transplantation of Schwann cells (SCs) is a promising treatment modality to improve neuronal regeneration. Identification of the transplanted cells is an important step when studying the development of this method. Genetic labeling is the most stable and reliable method of cell identifi